Researchers have identified mutations that are associated with significantly different risks of breast and ovarian cancers. Authors say the results — which show that some mutations confer higher risks of breast cancer, while other mutations show higher risks of ovarian cancer — may lead to more effective cancer risk assessment, care and prevention strategies for health care providers and carriers.